Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

Jay Giri; Ashwin Nathan

doi:10.1016/j.jcin.2017.12.002

JACC: Cardiovascular Interventions

Volume 11, Issue 7, April 2018 DOI: 10.1016/j.jcin.2017.12.002

PDF Article

Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

Jay Giri and Ashwin Nathan

This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article.

Author + information

vol. 11 no. 7 635-637

DOI:

https://doi.org/10.1016/j.jcin.2017.12.002

Published By:

JACC: Cardiovascular Interventions

Print ISSN:

1936-8798

Online ISSN:

1876-7605

History:

Published online April 2, 2018.

Article Versions

previous version (March 14, 2018 - 11:00).
You are viewing the most recent version of this article.

2018 American College of Cardiology Foundation

Author Information

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.